Back to search

Article

Characterizing Human Mesenchymal Stromal Cells Immune Modulatory Potency Using Targeted Lipidomic Profiling of Sphingolipids

2021-06-02

Abstract excerpt

<h4>ABSTRACT</h4> Cell therapies are expected to increase over the next decade due to increasing demand for clinical applications. Mesenchymal stromal cells (MSCs) have been explored to treat a number of diseases, with some successes in early clinical trials. Despite early successes, poor MSC characterization results in lessened therapeutic capacity once in vivo . Here, we characterized bone–marrow (BM), adipose...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d5500e8-fcf6-541f-baa9-e201a789df12
DOI
10.1101/2021.06.01.446428
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Characterizing Human Mesenchymal Stromal Cells Immune Modulatory Potency Using Targeted Lipidomic Profiling of SphingolipidsDOI 10.1101/2021.06.01.446428
Select a neighboring publication to make it the new centre.